Clinical Utility of Available Methods for Determining Platelet Function
- 1 January 1999
- journal article
- review article
- Published by S. Karger AG in Cardiology
- Vol. 92 (4) , 240-247
- https://doi.org/10.1159/000006981
Abstract
Determination of platelet function has become increasingly important as new antiplatelet drugs are being developed. Objective means to monitor the pharmacological effects of these agents, in order to maximize efficacy and minimize toxicity, is needed. The available methods for determination of platelet function at the current time are reviewed, including platelet aggregometry, the PFA-100, flow cytometry, platelet contractile force, the rapid platelet function assay, the clot signature analyzer, Sonoclot, and thromboelastography. The principle, advantages, disadvantages, and clinical utility of each method is presented. The uses of the various methods of determining platelet function reported in the literature are summarized, in an effort to provide information regarding the applicability of those different methods.This publication has 9 references indexed in Scilit:
- ForewordThe American Journal of Cardiology, 1999
- Overview of Platelet Physiology and Laboratory Evaluation of Platelet FunctionClinical Obstetrics and Gynecology, 1999
- Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulantTransfusion Medicine, 1999
- Increased binding of fibrinogen to glycoprotein IIIa-Proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular diseaseEuropean Heart Journal, 1999
- Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HAPARG StudyAtherosclerosis, 1999
- Rapid in vitro biocompatibility assay of endovascular stents by flow cytometry using platelet activation and platelet-leukocyte aggregationCytometry, 1999
- Perioperative hypercoagulability in uremic patients: A viscoelastic studyJournal of Clinical Anesthesia, 1997
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- OPTIMISATION OF PLATELET AGGREGOMETRY UTILISING MICOTITREPLATE TECHNOLOGY AND INTEGRATED SOFTWAREThrombosis Research, 1996